Actively Recruiting
Cardiovascular Risk Assessment and Dynamic Monitoring-based Prevention Trial
Led by Peking University · Updated on 2024-11-15
22032
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
P
Peking University
Lead Sponsor
Y
Yinzhou District Center for Disease Control and Prevention
Collaborating Sponsor
AI-Summary
What this Trial Is About
The CRITICALLY study is a cluster randomized trial that will evaluate the effectiveness of a risk-based dynamic monitoring strategy for the primary prevention of cardiovascular high-risk Chinese adults.
CONDITIONS
Official Title
Cardiovascular Risk Assessment and Dynamic Monitoring-based Prevention Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Residents in the Yinzhou District with a unique health ID
- Aged 40 to 79 years at the baseline enrollment
- High risk of cardiovascular disease evaluated by the 2019 WHO laboratory-based risk models (10-year risk ≥10%)
You will not qualify if you...
- History of coronary heart disease, stroke, or heart failure
- Diagnosis of cancer
- Refusal to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yinzhou District Center for Disease Control and Prevention
Ningbo, Zhejiang, China, 315100
Actively Recruiting
Research Team
X
Xun TANG, PhD, MHS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here